BioCentury
ARTICLE | Clinical News

Zanolimumab: Development discontinued

October 13, 2008 7:00 AM UTC

Genmab said it will discontinue development of zanolimumab, though patients already enrolled in an ongoing Phase III trial for CTCL and a Phase II trial for non-cutaneous T cell lymphoma (NCTCL) would...